CA2529003A1 - Cellules souches de la crete neurale et utilisation de ces cellules - Google Patents

Cellules souches de la crete neurale et utilisation de ces cellules Download PDF

Info

Publication number: CA2529003A1
Authority: CA; Canada
Prior art keywords: cells; ncscs; ncsc; culture; cell
Prior art date: 2005-12-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002529003A

Other languages

English (en)

Inventor

Freda Miller

Ian Mckenzie

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hospital for Sick Children HSC

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-05

Filing date

2005-12-05

Publication date

2007-06-05

2005-12-05 Application filed by Individual filed Critical Individual

2005-12-05 Priority to CA002529003A priority Critical patent/CA2529003A1/fr

2007-06-05 Publication of CA2529003A1 publication Critical patent/CA2529003A1/fr

Status Abandoned legal-status Critical Current

Links

210000000130 stem cell Anatomy 0.000 title claims abstract description 19
210000000933 neural crest Anatomy 0.000 title claims abstract description 13
210000004027 cell Anatomy 0.000 claims abstract description 167
238000000034 method Methods 0.000 claims abstract description 57
210000002569 neuron Anatomy 0.000 claims abstract description 38
241000124008 Mammalia Species 0.000 claims abstract description 22
230000001537 neural effect Effects 0.000 claims abstract description 14
108090000623 proteins and genes Proteins 0.000 claims description 41
210000001519 tissue Anatomy 0.000 claims description 32
102000004169 proteins and genes Human genes 0.000 claims description 25
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 22
108010057417 polysialyl neural cell adhesion molecule Proteins 0.000 claims description 19
102000008730 Nestin Human genes 0.000 claims description 18
108010088225 Nestin Proteins 0.000 claims description 18
210000005055 nestin Anatomy 0.000 claims description 18
210000000329 smooth muscle myocyte Anatomy 0.000 claims description 17
102100037362 Fibronectin Human genes 0.000 claims description 16
108010067306 Fibronectins Proteins 0.000 claims description 16
-1 S100.beta. Proteins 0.000 claims description 16
201000010099 disease Diseases 0.000 claims description 16
230000001464 adherent effect Effects 0.000 claims description 15
210000004153 islets of langerhan Anatomy 0.000 claims description 15
210000004248 oligodendroglia Anatomy 0.000 claims description 15
210000004116 schwann cell Anatomy 0.000 claims description 15
230000001225 therapeutic effect Effects 0.000 claims description 15
210000001789 adipocyte Anatomy 0.000 claims description 14
210000001130 astrocyte Anatomy 0.000 claims description 14
210000001612 chondrocyte Anatomy 0.000 claims description 14
210000002808 connective tissue Anatomy 0.000 claims description 14
210000002889 endothelial cell Anatomy 0.000 claims description 14
210000003494 hepatocyte Anatomy 0.000 claims description 14
210000003292 kidney cell Anatomy 0.000 claims description 14
210000005265 lung cell Anatomy 0.000 claims description 14
210000002752 melanocyte Anatomy 0.000 claims description 14
102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims description 13
101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 claims description 13
210000004413 cardiac myocyte Anatomy 0.000 claims description 13
210000000845 cartilage Anatomy 0.000 claims description 13
210000002919 epithelial cell Anatomy 0.000 claims description 13
210000002363 skeletal muscle cell Anatomy 0.000 claims description 13
238000012258 culturing Methods 0.000 claims description 12
101100518995 Caenorhabditis elegans pax-3 gene Proteins 0.000 claims description 10
KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 claims description 10
101100518997 Mus musculus Pax3 gene Proteins 0.000 claims description 10
210000000276 neural tube Anatomy 0.000 claims description 10
239000008194 pharmaceutical composition Substances 0.000 claims description 10
102100032912 CD44 antigen Human genes 0.000 claims description 9
101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 9
210000002966 serum Anatomy 0.000 claims description 9
239000013604 expression vector Substances 0.000 claims description 8
108091008794 FGF receptors Proteins 0.000 claims description 7
101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 claims description 7
102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 claims description 7
239000000758 substrate Substances 0.000 claims description 7
210000001035 gastrointestinal tract Anatomy 0.000 claims description 3
238000001727 in vivo Methods 0.000 claims description 3
230000001939 inductive effect Effects 0.000 claims description 2
210000003169 central nervous system Anatomy 0.000 abstract description 7
238000002955 isolation Methods 0.000 abstract description 4
239000000203 mixture Substances 0.000 abstract description 3
230000035755 proliferation Effects 0.000 abstract description 3
210000001428 peripheral nervous system Anatomy 0.000 abstract description 2
238000002054 transplantation Methods 0.000 abstract description 2
230000004069 differentiation Effects 0.000 description 7
102000008763 Neurofilament Proteins Human genes 0.000 description 6
108010088373 Neurofilament Proteins Proteins 0.000 description 6
208000035475 disorder Diseases 0.000 description 6
210000005044 neurofilament Anatomy 0.000 description 6
210000004498 neuroglial cell Anatomy 0.000 description 6
239000003102 growth factor Substances 0.000 description 5
239000013598 vector Substances 0.000 description 5
108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 4
102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 4
108010025020 Nerve Growth Factor Proteins 0.000 description 4
SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
230000001105 regulatory effect Effects 0.000 description 4
229930002330 retinoic acid Natural products 0.000 description 4
229960001727 tretinoin Drugs 0.000 description 4
108010063104 Apoptosis Regulatory Proteins Proteins 0.000 description 3
102000010565 Apoptosis Regulatory Proteins Human genes 0.000 description 3
108020004414 DNA Proteins 0.000 description 3
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 3
208000018737 Parkinson disease Diseases 0.000 description 3
230000002159 abnormal effect Effects 0.000 description 3
210000005064 dopaminergic neuron Anatomy 0.000 description 3
210000002257 embryonic structure Anatomy 0.000 description 3
208000014674 injury Diseases 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
108010022794 2',3'-Cyclic-Nucleotide Phosphodiesterases Proteins 0.000 description 2
102000012438 2',3'-Cyclic-Nucleotide Phosphodiesterases Human genes 0.000 description 2
102000007469 Actins Human genes 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
240000002791 Brassica napus Species 0.000 description 2
208000024172 Cardiovascular disease Diseases 0.000 description 2
108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 2
102100031614 Ciliary neurotrophic factor Human genes 0.000 description 2
108091026890 Coding region Proteins 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 2
241000289659 Erinaceidae Species 0.000 description 2
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
102100021066 Fibroblast growth factor receptor substrate 2 Human genes 0.000 description 2
102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 2
108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
101000818410 Homo sapiens Fibroblast growth factor receptor substrate 2 Proteins 0.000 description 2
101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 description 2
101001076408 Homo sapiens Interleukin-6 Proteins 0.000 description 2
101000996663 Homo sapiens Neurotrophin-4 Proteins 0.000 description 2
101000707152 Homo sapiens SH2B adapter protein 1 Proteins 0.000 description 2
101000868152 Homo sapiens Son of sevenless homolog 1 Proteins 0.000 description 2
101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
102000008070 Interferon-gamma Human genes 0.000 description 2
108010074328 Interferon-gamma Proteins 0.000 description 2
102000015696 Interleukins Human genes 0.000 description 2
108010063738 Interleukins Proteins 0.000 description 2
102100027670 Islet amyloid polypeptide Human genes 0.000 description 2
102100032352 Leukemia inhibitory factor Human genes 0.000 description 2
108090000581 Leukemia inhibitory factor Proteins 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
208000021642 Muscular disease Diseases 0.000 description 2
108090000742 Neurotrophin 3 Proteins 0.000 description 2
102000001253 Protein Kinase Human genes 0.000 description 2
101100517381 Rattus norvegicus Ntrk1 gene Proteins 0.000 description 2
102100031770 SH2B adapter protein 1 Human genes 0.000 description 2
102100040247 Tumor necrosis factor Human genes 0.000 description 2
241000700605 Viruses Species 0.000 description 2
108700000711 bcl-X Proteins 0.000 description 2
102000055104 bcl-X Human genes 0.000 description 2
230000008901 benefit Effects 0.000 description 2
238000002659 cell therapy Methods 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
230000002526 effect on cardiovascular system Effects 0.000 description 2
229940044627 gamma-interferon Drugs 0.000 description 2
230000002518 glial effect Effects 0.000 description 2
230000036541 health Effects 0.000 description 2
210000003958 hematopoietic stem cell Anatomy 0.000 description 2
238000012744 immunostaining Methods 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
229940047122 interleukins Drugs 0.000 description 2
239000002502 liposome Substances 0.000 description 2
210000001577 neostriatum Anatomy 0.000 description 2
208000015122 neurodegenerative disease Diseases 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
230000002062 proliferating effect Effects 0.000 description 2
108060006633 protein kinase Proteins 0.000 description 2
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
210000003491 skin Anatomy 0.000 description 2
210000002460 smooth muscle Anatomy 0.000 description 2
208000020431 spinal cord injury Diseases 0.000 description 2
238000010186 staining Methods 0.000 description 2
210000003523 substantia nigra Anatomy 0.000 description 2
108020005544 Antisense RNA Proteins 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
101100261976 Drosophila melanogaster trk gene Proteins 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
208000034693 Laceration Diseases 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
241001504519 Papio ursinus Species 0.000 description 1
238000010240 RT-PCR analysis Methods 0.000 description 1
101100537955 Schizosaccharomyces pombe (strain 972 / ATCC 24843) trk1 gene Proteins 0.000 description 1
101710195626 Transcriptional activator protein Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
229960004373 acetylcholine Drugs 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
210000004507 artificial chromosome Anatomy 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
210000002459 blastocyst Anatomy 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
238000010322 bone marrow transplantation Methods 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000006727 cell loss Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000003412 degenerative effect Effects 0.000 description 1
238000002224 dissection Methods 0.000 description 1
229960003638 dopamine Drugs 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
229960003692 gamma aminobutyric acid Drugs 0.000 description 1
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
229930195712 glutamate Natural products 0.000 description 1
229940049906 glutamate Drugs 0.000 description 1
229960002449 glycine Drugs 0.000 description 1
210000002064 heart cell Anatomy 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
238000011134 hematopoietic stem cell transplantation Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
210000002894 multi-fate stem cell Anatomy 0.000 description 1
201000006417 multiple sclerosis Diseases 0.000 description 1
210000003061 neural cell Anatomy 0.000 description 1
210000001982 neural crest cell Anatomy 0.000 description 1
210000001178 neural stem cell Anatomy 0.000 description 1
230000000626 neurodegenerative effect Effects 0.000 description 1
230000000926 neurological effect Effects 0.000 description 1
230000004031 neuronal differentiation Effects 0.000 description 1
239000002858 neurotransmitter agent Substances 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
238000000053 physical method Methods 0.000 description 1
210000004694 pigment cell Anatomy 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
239000002243 precursor Substances 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
210000004129 prosencephalon Anatomy 0.000 description 1
238000000746 purification Methods 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
238000011160 research Methods 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
230000028327 secretion Effects 0.000 description 1
229940076279 serotonin Drugs 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
239000007858 starting material Substances 0.000 description 1
238000011476 stem cell transplantation Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
230000032258 transport Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
230000008736 traumatic injury Effects 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
230000009385 viral infection Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Zoology (AREA)
Neurology (AREA)
Wood Science & Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Physical Education & Sports Medicine (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Cell Biology (AREA)
Developmental Biology & Embryology (AREA)
Microbiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

CA002529003A 2005-12-05 2005-12-05 Cellules souches de la crete neurale et utilisation de ces cellules Abandoned CA2529003A1 (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA002529003A CA2529003A1 (fr)	2005-12-05	2005-12-05	Cellules souches de la crete neurale et utilisation de ces cellules

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA002529003A CA2529003A1 (fr)	2005-12-05	2005-12-05	Cellules souches de la crete neurale et utilisation de ces cellules

Publications (1)

Publication Number	Publication Date
CA2529003A1 true CA2529003A1 (fr)	2007-06-05

Family

ID=38121178

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002529003A Abandoned CA2529003A1 (fr)	2005-12-05	2005-12-05	Cellules souches de la crete neurale et utilisation de ces cellules

Country Status (1)

Country	Link
CA (1)	CA2529003A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2845898A4 (fr) *	2012-05-04	2015-12-09	Univ Inje Ind Acad Cooperation	Procédé pour cultiver des cellules souches de crête neurale, et utilisation de celles-ci
CN107475200A (zh) *	2017-08-08	2017-12-15	浙江大学	一种背根神经节源的神经嵴干细胞的分离、培养与分化方法

2005
- 2005-12-05 CA CA002529003A patent/CA2529003A1/fr not_active Abandoned

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2845898A4 (fr) *	2012-05-04	2015-12-09	Univ Inje Ind Acad Cooperation	Procédé pour cultiver des cellules souches de crête neurale, et utilisation de celles-ci
CN107475200A (zh) *	2017-08-08	2017-12-15	浙江大学	一种背根神经节源的神经嵴干细胞的分离、培养与分化方法
CN107475200B (zh) *	2017-08-08	2020-12-22	浙江大学	一种背根神经节源的神经嵴干细胞的分离、培养与分化方法

Publication	Publication Date	Title
US6949380B1 (en)	2005-09-27	Transdifferentiation of epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells
EP1261694B1 (fr)	2008-01-16	CELLULES SOUCHES MULTIPOTENTES PRODUITES A PARTIR DE CELLULES Du STROMA ADIPEUX ET leurs UTILISATIONS
EP1438393B1 (fr)	2008-02-27	Differentiation de moelle osseuse totale
KR20060037346A (ko)	2006-05-03	휘돌기교세포 전구세포 및 이를 획득하고 배양하는 방법
Walsh et al.	2005	Human central nervous system tissue culture: a historical review and examination of recent advances
WO2002036749A2 (fr)	2002-05-10	Cellules souches de cadavres
CN106574243B (zh)	2021-02-23	表达腺病毒e4orf1的神经细胞及其制备方法和应用
Zeng et al.	2005	Co-transplantation of schwann cells promotes the survival and differentiation of neural stem cells transplanted into the injured spinal cord
JP2004511266A (ja)	2004-04-15	間葉間質細胞に対する治療的利用法
WO2016039462A1 (fr)	2016-03-17	Cellules de schwann et procédé de préparation associé
US20050176141A1 (en)	2005-08-11	Compositions and methods relating to culturing neural stem cells with bone marrow stromal cells
US20050214941A1 (en)	2005-09-29	Expansion of neural stem cells with LIF
KR20200026984A (ko)	2020-03-11	랜드마크 전사 인자를 사용한 줄기 세포 분화에 의한 신경 전구 세포, 핍지교세포 전구 세포, 및 핍지교세포의 유도
US20060263876A1 (en)	2006-11-23	Neural crest stem cells and uses thereof
KR101743799B1 (ko)	2017-06-07	아스코르브산을 이용하여 인간 역분화 줄기세포를 신경능선 세포로 분화시키는 방법 및 상기 방법에 의해 형성된 신경능선 세포
CA2529003A1 (fr)	2007-06-05	Cellules souches de la crete neurale et utilisation de ces cellules
JP2019076008A (ja)	2019-05-23	骨細胞、軟骨細胞、脂肪細胞、または神経細胞に分化可能な前駆細胞、その作製方法、およびその使用方法
WO2025026225A1 (fr)	2025-02-06	Kit pour induire la différenciation de cellules souches en cellules précurseurs de neurones moteurs et/ou en neurones moteurs et son utilisation
WO2005095587A1 (fr)	2005-10-13	Processus de production de cellules souches somatiques differenciées des cellules souches embryonnaires et utilisation de celles-ci
HK1095359A (en)	2007-05-04	Oligodendrocyte precursor cells and methods of obtaining and culturing the same
HK40003991A (en)	2020-04-17	Culture method to obtain and maintain a pure or enriched population of mammal neural stem cells and/or neural progenitor cells
EP1918366A1 (fr)	2008-05-07	Cellules souches pleuripotent générées à partir de cellules stromales dérivées de tissus adipeux et utilisations associées
HK40020599B (zh)	2025-01-28	通过利用地标转录因子的干细胞分化诱导神经祖细胞、寡树突细胞祖细胞及寡树突细胞
HK1117193A (en)	2009-01-09	Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof

Legal Events

Date	Code	Title	Description
2011-12-05	FZDE	Dead